JAN 22, 2014 12:00 AM PST

Positive Results through a Positive Message

WRITTEN BY: Jen Ellis
The placebo effect, where people receive dummy medications but report improvement in their condition anyway, has long been established-but does it matter how the medications are presented? A new study with migraine patients suggests that positive messaging is so powerful that it can increase the effectiveness of treatments, and that physicians must take care in how medications in trial stages are presented to patients. The study was published recently in Science Translational Medicine.

The study, combining efforts from Harvard University and the nearby Beth Israel Deaconess Hospital, involved 66 people who suffered from migraine headaches. Most studies try to determine the effectiveness of a medication and minimize the potential placebo effect. In this case, the intent was to use a medication already known to be effective, then quantify and contrast the amounts of relief that came strictly from the medication and alternately from the placebo effect.

To record a baseline pain level, the patients all agreed to delay taking any pain relief for a few hours during a migraine attack. For six subsequent migraine headaches, the subjects were given an envelope containing their medication, along with a message. The message fell in one of three categories: positive -the medication they received was rizatriptan (trade name Maxalt), which is known to be useful in migraine relief; negative-the medication is a placebo with no expectation of effect on migraine symptoms; or neutral-the medication could be either one.

However, the medications were switched in some cases so the medication did not match up with the message that the patients received. In doing so, the researchers were able to form sizable populations that were given expectations that did not meet the presumed effect of their medication.

To nobody's surprise, Maxalt was more effective than the placebo in head-to-head comparison. But the researchers were surprised to find that under all three potential messages, at least half of the total relief from pain could be attributed to the placebo effect. When subjects received correctly labeled Maxalt, their assessment of pain relief was over twice as much as the group that received Maxalt labeled incorrectly as a placebo. Also, the positive message showed improved results in pain relief in both cases, whether patients received Maxalt or a placebo.

Even in the cases where patients were given placebos that were explicitly labeled, pain relief was reported. This challenges the standard belief that placebos are effective because patients think that they are receiving an effective drug, but it's not obvious what theory should replace that belief.

By isolating the placebo effect, the study shows that a positive message and expectation of relief may improve the effectiveness of treatments (and conversely, that a poor message may hamper the effectiveness). It also calls into question theories as to how placebos actually work.

Does this study imply that all medications should be labeled "Quadruple-strength, super-effective wonder drug?" No-although it would be interesting to study the effect of inflated claims. It does, however, provide significant evidence that a positive message and high expectations are important in treatment, and that researchers must be careful to not skew studies of unknown drugs by not giving consistent messages.
About the Author
You May Also Like
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
Skin Deep: Handheld Device Sees the Earliest Signs of Cancer
Researchers have developed a handheld device that can image structures under the skin at resolutions 100 times greater t ...
APR 23, 2020
Cardiology
APR 23, 2020
Arteries Respond in Different Ways in Females and Males
Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myograp ...
MAY 02, 2020
Cancer
MAY 02, 2020
Tracking DNA Methylation as a Prognostic Marker
In the modern age of biological research, one of the tools that have become readily available in the ever-increasing dat ...
MAY 03, 2020
Microbiology
MAY 03, 2020
Understanding How Lyme Disease Persists in the Body
Lyme disease is a confounding illness that can be difficult to diagnose, and can cause a wide range of serious health pr ...
MAY 06, 2020
Cardiology
MAY 06, 2020
Can Alcohol Consumption Increase Your Risk of Peripheral Arterial Disease?
Peripheral Arterial Disease (PAD) is a chronic disease where plaque builds up in the arteries in the legs. This buildup ...
MAY 09, 2020
Chemistry & Physics
MAY 09, 2020
Blood test monitors fat intake
Research published in the Journal of Lipid Research highlights a new blood test that is able to monitor an individual&rs ...
Loading Comments...